Company Overview
- Headquarters
- 1200 Avenue of the Americas Ste 200, New York NY
- Website
- imux.com
- Phone
- (332) 255-9818
- Employees
- 86
- Founded in
- 2016
- Industry
- BioTech/Drugs
- Stock Symbol
- IMUX
- NAICS Code
-
NAICS Code 541 CompaniesNAICS Code 541711 CompaniesNAICS Code 54 CompaniesNAICS Code 5417 CompaniesNAICS Code 54171 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 CompaniesSIC Code 80 Companies
Financials & Stats
Revenue
$6B
Total Funding Amount
$63M
Who is Immunic Therapeutics
Immunic Therapeutics is a biotechnology company headquartered in New York, New York. The company employs 86 people and reported revenue of $6.1 million. Immunic is traded on the Nasdaq stock exchange under the ticker symbol IMUX. Immunic Therapeutics focuses on developing orally administered, small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. Their clinical pipeline consists of promising treatments aimed at improving the lives of patients suffering from these debilitating conditions. Immunic's commitment to developing innovative, orally administered therapies sets them apart in the field of inflammatory and autoimmune disease treatment. This approach offers patients a convenient and potentially more effective alternative to traditional treatment options. For more information about Immunic Therapeutics and their groundbreaking research, please visit their website at imux.com.
Company Leadership
Companies Similar to Immunic Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Immunic Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 6M | 21 | Rockville, MD | 2011 | |
| 6M | 43 | Carlsbad, CA | 1997 | |
| 6M | 10 | San Jose, CA | 2004 | |
| 6M | 85 | Lake Forest, CA | 1994 | |
| 6M | 54 | San Francisco, CA | 2016 |